Painkiller Darvon and Darvocet Pulled from US Markets
FDA, U.S. Food and Drug Administration has announced that Xanodyne Pharmaceuticals the maker of Darvon and Darvocet -voluntarily withdraw these painkillers the from US markets. The active ingredient propoxyphene, “has recently completed new clinical trails that was designed to assess the impact on the electrical activity of the heart,” Dr. John Jenkins, director of FDA’s Office of New Drugs, Center for Drug Evaluation and Research. The trail showed propoxyphene can cause potentially serious or even deadly heart rhythm, alled arrhythmias, he said. “We concluded the pain benefits of propoxphene no longer outweighted the heart risk and that propoxyphene should no longer be sold in the United States.” Jenkins said. The FDA has also asked that generic versions of the drug be withdrawn. In 2009, approximately 10 million people in the US were taking propoxyphene.
In Virginia, people trust Kalfus & Nachman, Attorneys at Law to assist with every step of pursuing a personal injury case. Our product liability lawyers have extensive experience in handling pharmaceutical injury claims, and can help you get on with your life with peace of mind, knowing you have been fully compensated under the law. Please contact our defective product attorneys to schedule your private, no-cost pharmaceutical injuryconsultation in Norfolk, Hampton, Newport News, Portsmouth, Roanoke, and Virginia Beach, Virginia. “Tell Them You Mean Business.”
This entry was posted on Tuesday, November 30th, 2010 at 8:17 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
